Trials / Recruiting
RecruitingNCT04624555
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Case Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.
Detailed description
Participants who were diagnosed with Stage I-III colorectal cancer will undergo testing with mt-sDNA followed by a questionnaire about satisfaction with mt-sDNA (multitarget stool DNA panel), prior to their scheduled colonoscopies at years 1 and 4 after diagnosis. Participants will be asked to provide a stool sample for mt-sDNA (Cologuard) testing that will be collected within 90 days before their scheduled colonoscopy. The kit will be given to the participant by study personnel and mailed back directly to Exact Science.
Conditions
- Adenocarcinoma of the Colon
- Adenocarcinoma of the Rectum
- Stage I Colorectal Cancer
- Stage II Colorectal Cancer
- Stage III Colorectal Cancer
Timeline
- Start date
- 2022-10-31
- Primary completion
- 2026-09-01
- Completion
- 2026-09-01
- First posted
- 2020-11-12
- Last updated
- 2026-04-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04624555. Inclusion in this directory is not an endorsement.